Christopher L. Murriel
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Pathology and Forensic Medicine top 10%
- Cardiac Ischemia and Reperfusion
Papers in
-
- Cell death mechanisms and regulation 2
- Epigenetics and DNA Methylation 2
- Mitochondrial Function and Pathology 2
- Ubiquitin and proteasome pathways 1
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Co-authors
- Daria Mochly‐Rosen (4 shared papers)Eric N. Churchill (2 shared papers)Luke I. Szweda (2 shared papers)Steven F. Dowdy (1 shared paper)Koichi Inagaki (1 shared paper)Mallika Singh (1 shared paper)Leisa Johnson (1 shared paper)Marcus Fischer (3 shared papers)
- Journals
- Cancer Research (4 papers)Journal for ImmunoTherapy of Cancer (1 paper)Expert Opinion on Drug Delivery (1 paper)Archives of Biochemistry and Biophysics (1 paper)Nature (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Christopher L. Murriel
13 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Oncology 313
- Pathology and Forensic Medicine 158
- Molecular Biology 641
- Cancer Research 85
- Epidemiology 143
Countries citing papers authored by Christopher L. Murriel
This map shows the geographic impact of Christopher L. Murriel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Murriel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Murriel more than expected).
Fields of papers citing papers by Christopher L. Murriel
This network shows the impact of papers produced by Christopher L. Murriel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Murriel. The network helps show where Christopher L. Murriel may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher L. Murriel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 323 | |
| 2 | 2004 | 167 | |
| 3 | 2017 | 122 | |
| 4 | 2003 | 114 | |
| 5 | 2005 | 111 | |
| 6 | 2012 | 91 | |
| 7 | 2006 | 89 | |
| 8 | 2017 | 39 | |
| 9 | 2017 | 8 | |
| 10 | 2003 | 8 | |
| 11 | 2015 | 2 | |
| 12 | 2015 | 1 | |
| 13 | 2018 | 1 |
About Christopher L. Murriel
Christopher L. Murriel is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Immunology and Organic Chemistry, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers), Cardiac Ischemia and Reperfusion (2 papers), Epigenetics and DNA Methylation (2 papers), Immunotherapy and Immune Responses (2 papers), Mitochondrial Function and Pathology (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (313 citations), Pathology and Forensic Medicine (158 citations), Molecular Biology (641 citations), Cancer Research (85 citations) and Epidemiology (143 citations). Christopher L. Murriel has collaborated with scholars based in United States and France. Frequent co-authors include Daria Mochly‐Rosen, Eric N. Churchill, Luke I. Szweda, Steven F. Dowdy, Koichi Inagaki, Mallika Singh, Leisa Johnson, Marcus Fischer, Jennifer Cain and Timothy Hoey. Their work appears in journals such as Cancer Research, Journal for ImmunoTherapy of Cancer, Expert Opinion on Drug Delivery, Archives of Biochemistry and Biophysics and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.